NASDAQ$PNTG

The Pennant Group Inc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Pennant Group reported an increase in total revenue and net income compared to the prior year quarter.

The Pennant Group reported a revenue of $118.4 million, a 5.7% increase year-over-year. Net income for the quarter was $4.8 million. The company also completed the acquisition of Ardent Hospice and Palliative Care and Kenosha Visiting Nurse Association.

  • Total revenue increased by 5.7% year-over-year to $118.4 million.
  • Net income was $4.8 million.
  • Home Health and Hospice Services segment revenue increased by 8.6% year-over-year to $85.8 million.
  • Senior Living Services segment revenue decreased slightly by 1.1% year-over-year to $32.6 million.

Headline financials

Total Revenue

$118M

Previous: $112M+5.7%
EPS (adj)

$0.14

Previous: $0.11+27.3%
Total Home Health Admissions

10.2K

Previous: 9.2K+10.2%
Medicare HH Admissions

4.6K

No prior period
Hospice Avg Daily Census

2.3K

Previous: 2.3K-1.9%
Capital Expenditures

-$10.4M

Previous: -$4.14M-151.6%
Free Cash Flow

-$5.6M

Previous: -$2.9M-93.0%
Net Income

$4.83M

Previous: $1.25M+288.0%
Operating Income

$7.14M

Previous: $1.7M+319.7%
Gross Profit

-$94.7M

Previous: -$89.6M-5.6%
Cash & Equivalents

$2.96M

Previous: $3.71M-20.3%
Total Assets

$505M

Previous: $529M-4.6%
Stock-Based Comp

-$2.75M

Previous: $2.57M-207.0%

Revenue & EPS history

Pennant Group · Revenue · Quarterly

$118M

Q3 2022+5.7%vs Q3 2021
Beat estimate in 12 of 14 quarters(86%)
ActualEstimate

Revenue by segment

Pennant Group · $37.3M total across 1 segment · Q2 2023

  • Senior Living Services
    $37.3M

Forward guidance

Management anticipates 2022 annual guidance of total revenue between $458 million and $462 million, earnings per diluted share between $0.55 and $0.60, and adjusted EBITDA between $31.0 million and $33.5 million.

Tailwinds

  • Total revenue between $458 million and $462 million.
  • Earnings per diluted share between $0.55 and $0.60.
  • Adjusted EBITDA between $31.0 million and $33.5 million.
  • Based on diluted weighted average shares outstanding of approximately 30.3 million
  • Effective tax rate of 25.6%

Headwinds

  • Assumes anticipated reimbursement rate adjustments.
  • Assumes no unannounced acquisitions.
  • Assumes the lingering effects of COVID-19.
  • Excludes the tax-effected costs at start-up operations.
  • Excludes share-based compensation, acquisition-related costs, and loss on disposition of assets and impairments.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

-0.4%

Avg return

Earnings day

+5.0%

Avg return

5 days after

+5.6%

Avg return

30 days after

40%

12 / 30 earnings

Positive

+27.4%

Q2 2020

Best reaction

-18.7%

Q3 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.4%+8.4%+0.5%
Q4 2025-7.8%-0.2%-9.8%
Q3 2025-5.8%+0.4%+16.1%
Q1 2025+3.7%+10.1%+10.1%
Q4 2024-10.8%-8.1%-3.6%
Q3 2024+0.6%+6.4%-5.9%
Q2 2024+0.3%+8.2%+18.3%
Q1 2024-2.3%+5.8%+11.3%
Q4 2023+12.4%+13.3%+18.3%
Q3 2023+7.6%+5.7%+13.6%
Q2 2023-1.2%+8.9%+1.3%
Q1 2023-9.4%-14.7%-6.8%
Q4 2022+11.3%+20.7%+8.9%
Q3 2022-11.4%-10.8%-20.0%
Q2 2022+6.8%+12.6%+0.6%
Q1 2022+6.6%+26.4%+21.3%
Q4 2021-7.5%-7.9%+12.9%
Q3 2021-18.7%-6.9%-21.1%
Q2 2021-5.8%-15.0%+0.0%
Q1 2021-2.2%-9.4%-14.2%
Q4 2020-8.3%-7.5%-16.9%
Q3 2020-0.5%+5.3%+21.1%
Q2 2020+27.4%+23.8%+15.9%
Q1 2019+15.1%+51.2%+45.5%
Q1 2020+15.1%+51.2%+45.5%
Q2 2019-3.3%-13.7%-43.7%
Q4 2017-3.3%-13.7%-43.7%
Q4 2019-3.3%-13.7%-43.7%
Q3 2019-10.5%+7.0%+68.4%
Q4 2018-10.5%+7.0%+68.4%
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro